Overview
Alessandra Boncoraglio practices in Milan, Italy. Her top areas of expertise are Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).
Her clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alessandra Boncoraglio
Is Alessandra Boncoraglio a top-rated expert for Primary Lateral Sclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Alessandra Boncoraglio is classified as an Experienced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alessandra Boncoraglio participate in research or clinical trials?
Yes. Alessandra Boncoraglio has published 10 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Alessandra Boncoraglio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral SclerosisMs. Boncoraglio isExperienced. Learn about Primary Lateral Sclerosis.